Robert Darwin

Robert-Darwin

Robert Darwin

Partner

London | 160 Queen Victoria Street, London EC4V 4QQ
+44 20 7184 7603 | +44 20 7184 7001

| vCard | PDF

Robert Darwin has a broad international practice focused on private equity and M&A. He executes the most strategic and critical private transactions for global corporates, funds and other private investors. Mr. Darwin advises clients across a wide range of industries including industrials, technology and retail.

Mr. Darwin is particularly known for his work with global life sciences and healthcare corporations and investors, The Legal 500 describing him as “hardworking, conscientious, and commercial.” He has led deals of all types in these industries, including strategic collaborations, acquisitions, private equity buyouts and venture deals. 

Experience
  • Merck KGaA on strategic M&A, including its up to €1 billion immuno-oncology collaboration with F-Star and licensing and collaboration arrangements.
  • Compass Pathways in relation to various funding rounds for its groundbreaking work with psilocybin.
  • One of the world's largest family offices on private equity and venture direct and co-investments in the life sciences and technology sectors.
  • Peprotech Inc., a leading manufacturer of cytokines and antibodies for scientific application, in relation to various European corporate matters.
  • The Craftory, the US$300 million challenger brand investment fund, in relation to its structuring and equity funding by two of the world’s largest family offices.
  • Lynwood Investments in relation to its sale of some of its interest in Waterstones Booksellers to Elliott Private Equity.
  • Sedgwick Claims Management (then a KKR portfolio company) in relation to its acquisition of Cunningham Lindsey in the insurance sector.
  • Judges Scientific plc in relation to various acquisitions in the life sciences and health care sector.
  • Advent International in relation to the disposal of Oxea, one of the largest global manufacturers of Oxo chemicals, to Oman Oil Company.
  • Parthenon Capital LLC in relation to its sale of Med-Tel UK Limited, a leading diagnostic group.
  • Intertek Group plc in relation to various corporate matters.
  • Mitsubishi Heavy Industries on its global joint venture in metals machinery technology (with Siemens AG).
  • Inchcape plc in relation to M&A.
  • Bank Otkritie in relation to its acquisition of Rocket Bank (backed by Runa Capital). 
  • BCG Digital Ventures, Deutsche Telekom Venture Fund and Berlin Hyp Venture Fund in relation to various venture investments.
  • Ares Capital and Lyceum Capital in relation to various equity co-investments.

Includes matters handled at Dechert or prior to joining the firm.

Education
  • Birmingham University, B.A., 2001
  • BPP Law School, PgDL, 2002
  • BPP Law School, LPC, 2003
Admissions
  • England and Wales